Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
113.31
+2.56 (2.31%)
At close: Aug 12, 2025, 4:00 PM
113.33
+0.02 (0.02%)
After-hours: Aug 12, 2025, 4:00 PM EDT
Jazz Pharmaceuticals Employees
Jazz Pharmaceuticals had 2,800 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,800
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,459,534
Profits / Employee
-$144,586
Market Cap
6.87B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,800 | 0 | - |
| Dec 31, 2023 | 2,800 | 0 | - |
| Dec 31, 2022 | 2,800 | -400 | -12.50% |
| Dec 31, 2021 | 3,200 | 1,260 | 64.95% |
| Dec 31, 2020 | 1,940 | 320 | 19.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
JAZZ News
- 6 days ago - Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma - PRNewsWire
- 6 days ago - US FDA approves Jazz Pharma's drug for rare brain tumor - Reuters
- 6 days ago - Jazz Pharmaceuticals plc (JAZZ) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Jazz Pharmaceuticals Announces Second Quarter 2025 Financial Results and Updates 2025 Financial Guidance - PRNewsWire
- 21 days ago - Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 5, 2025 - PRNewsWire
- 4 weeks ago - Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer - PRNewsWire
- 5 weeks ago - Is JAZZ Stock Undervalued At $110? - Forbes
- 5 weeks ago - Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor - Seeking Alpha